{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:44:40Z","timestamp":1792622680111,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study measured sleep quality among caregivers of patients with Dravet syndrome (DS) and assessed the impacts of mental health problems and caregiver burden on sleep quality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicenter, cross-sectional study of patients with DS and their caregivers throughout Germany consisted of a questionnaire and a prospective 4-week diary querying disease characteristics, demographic data, living conditions, nocturnal supervision, and caregivers\u2019 work situations. Sleep quality was assessed using the Pittsburgh Sleeping Quality Index (PSQI). The Hospital Anxiety and Depression Scale (HADS) and the Burden Scale for Family Caregivers (BSFC) were used to measure anxiety, symptoms of depression, and caregiver burden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our analysis included 108 questionnaires and 82 four-week diaries. Patients with DS were 49.1% male (n\u2009=\u200953), with a mean age of 13.5\u2009\u00b1\u200910.0\u00a0years. Caregivers were 92.6% (n\u2009=\u2009100) female, with a mean age of 44.7\u2009\u00b1\u200910.6\u00a0years. The overall mean PSQI score was 8.7\u2009\u00b1\u20093.5, with 76.9% of participants (n\u2009=\u200983) scoring 6 or higher, indicating abnormal sleep quality. The HADS for anxiety and depression had overall mean scores of 9.3\u2009\u00b1\u20094.3 and 7.9\u2009\u00b1\u20093.7, respectively; 61.8% and 50.9% of participants scored above the cutoff value of 8 for anxiety and depression, respectively. Statistical analyses revealed caregiver anxiety levels and patients\u2019 sleep disturbances as major factors influencing PSQI scores. The overall mean BSFC score of 41.7\u2009\u00b1\u200911.7 indicates a moderate burden, with 45.3% of caregivers scoring 42 or higher.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Sleep quality is severely affected among caregivers of patients with DS, correlating with anxiety, comorbidities, and patients\u2019 sleep disturbances. A holistic therapeutic approach should be implemented for patients with DS and their caregivers, focusing on the sleep quality and mental health of caregivers.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: German Clinical Trials Register (DRKS), DRKS00016967. Registered 27 May 2019, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.drks.de\/DRKS00016967\">http:\/\/www.drks.de\/DRKS00016967<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02697-3","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T10:01:49Z","timestamp":1682762509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-4357","authenticated-orcid":false,"given":"Margarita","family":"Maltseva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schubert-Bast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann Philipp","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"von Spiczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Trollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Hornemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin A.","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Kurlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd A.","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Polster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Syrbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Bertsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Bettendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Flege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6288-9915","authenticated-orcid":false,"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"issue":"Suppl 2","key":"2697_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","volume":"52","author":"C Dravet","year":"2011","unstructured":"Dravet C. The core Dravet syndrome phenotype. Epilepsia. 2011;52(Suppl 2):3\u20139.","journal-title":"Epilepsia"},{"key":"2697_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/14737175.2020.1801423","volume":"20","author":"A Strzelczyk","year":"2020","unstructured":"Strzelczyk A, Schubert-Bast S. Therapeutic advances in Dravet syndrome: a targeted literature review. Expert Rev Neurother. 2020;20:1065\u201379.","journal-title":"Expert Rev Neurother"},{"key":"2697_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.seizure.2016.10.014","volume":"44","author":"S Gataullina","year":"2017","unstructured":"Gataullina S, Dulac O. From genotype to phenotype in Dravet disease. Seizure. 2017;44:58\u201364.","journal-title":"Seizure"},{"key":"2697_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/dmcn.13591","volume":"60","author":"L Lagae","year":"2018","unstructured":"Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey. Dev Med Child Neurol. 2018;60:63\u201372.","journal-title":"Dev Med Child Neurol"},{"key":"2697_CR5","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/brain\/aws151","volume":"135","author":"A Brunklaus","year":"2012","unstructured":"Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012;135:2329\u201336.","journal-title":"Brain"},{"key":"2697_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/dmcn.12709","volume":"57","author":"C Rosander","year":"2015","unstructured":"Rosander C, Hallbook T. Dravet syndrome in Sweden: a population-based study. Dev Med Child Neurol. 2015;57:628\u201333.","journal-title":"Dev Med Child Neurol"},{"key":"2697_CR7","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1542\/peds.2015-1807","volume":"136","author":"YW Wu","year":"2015","unstructured":"Wu YW, Sullivan J, McDaniel SS, Meisler MH, Walsh EM, Li SX, Kuzniewicz MW. Incidence of Dravet syndrome in a US population. Pediatrics. 2015;136:e1310\u20135.","journal-title":"Pediatrics"},{"key":"2697_CR8","first-page":"625","volume":"50","author":"J Lee","year":"2020","unstructured":"Lee J, Lee C, Park WY, Lee J. Genetic diagnosis of Dravet syndrome using next generation sequencing-based epilepsy gene panel testing. Ann Clin Lab Sci. 2020;50:625\u201337.","journal-title":"Ann Clin Lab Sci"},{"key":"2697_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/jmg.2008.062323","volume":"46","author":"C Depienne","year":"2009","unstructured":"Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, Keren B, Abert B, Gautier A, Baulac S, Arzimanoglou A, Cazeneuve C, Nabbout R, LeGuern E. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet. 2009;46:183\u201391.","journal-title":"J Med Genet"},{"issue":"Suppl 3","key":"2697_CR10","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1017\/cjn.2016.243","volume":"43","author":"MB Connolly","year":"2016","unstructured":"Connolly MB. Dravet syndrome: diagnosis and long-term course. Can J Neurol Sci. 2016;43(Suppl 3):S3-8.","journal-title":"Can J Neurol Sci"},{"key":"2697_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","volume":"128","author":"MS Cooper","year":"2016","unstructured":"Cooper MS, McIntosh A, Crompton DE, McMahon JM, Schneider A, Farrell K, Ganesan V, Gill D, Kivity S, Lerman-Sagie T, McLellan A, Pelekanos J, Ramesh V, Sadleir L, Wirrell E, Scheffer IE. Mortality in Dravet syndrome. Epilepsy Res. 2016;128:43\u20137.","journal-title":"Epilepsy Res"},{"key":"2697_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108206","volume":"122","author":"C Goncalves","year":"2021","unstructured":"Goncalves C, Martins S, Fernandes L. Dravet syndrome: effects on informal caregivers\u2019 mental health and quality of life - A systematic review. Epilepsy Behav. 2021;122: 108206.","journal-title":"Epilepsy Behav"},{"key":"2697_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42466-022-00186-9","volume":"4","author":"A Strzelczyk","year":"2022","unstructured":"Strzelczyk A, Kurlemann G, Bast T, Bettendorf U, Kluger G, Mayer T, Neubauer BA, Polster T, von Spiczak S, Trollmann R, Wolff M, Toward T, Gruenert J, Gibson E, Pritchard C, Carroll J, Rosenow F, Schubert-Bast S. Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndrome. Neurol Res Pract. 2022;4:22.","journal-title":"Neurol Res Pract"},{"key":"2697_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.seizure.2018.12.018","volume":"65","author":"L Lagae","year":"2019","unstructured":"Lagae L, Irwin J, Gibson E, Battersby A. Caregiver impact and health service use in high and low severity Dravet syndrome: a multinational cohort study. Seizure. 2019;65:72\u20139.","journal-title":"Seizure"},{"key":"2697_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","volume":"74","author":"N Villas","year":"2017","unstructured":"Villas N, Meskis MA, Goodliffe S. Dravet syndrome: characteristics, comorbidities, and caregiver concerns. Epilepsy Behav. 2017;74:81\u20136.","journal-title":"Epilepsy Behav"},{"key":"2697_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.yebeh.2018.01.003","volume":"80","author":"JD Campbell","year":"2018","unstructured":"Campbell JD, Whittington MD, Kim CH, VanderVeen GR, Knupp KG, Gammaitoni A. Assessing the impact of caring for a child with Dravet syndrome: results of a caregiver survey. Epilepsy Behav. 2018;80:152\u20136.","journal-title":"Epilepsy Behav"},{"key":"2697_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yebeh.2017.06.012","volume":"74","author":"MP Jensen","year":"2017","unstructured":"Jensen MP, Liljenquist KS, Bocell F, Gammaitoni AR, Aron CR, Galer BS, Amtmann D. Life impact of caregiving for severe childhood epilepsy: results of expert panels and caregiver focus groups. Epilepsy Behav. 2017;74:135\u201343.","journal-title":"Epilepsy Behav"},{"key":"2697_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yebeh.2017.02.003","volume":"70","author":"MP Jensen","year":"2017","unstructured":"Jensen MP, Brunklaus A, Dorris L, Zuberi SM, Knupp KG, Galer BS, Gammaitoni AR. The humanistic and economic burden of Dravet syndrome on caregivers and families: implications for future research. Epilepsy Behav. 2017;70:104\u20139.","journal-title":"Epilepsy Behav"},{"key":"2697_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107094","volume":"108","author":"R Nabbout","year":"2020","unstructured":"Nabbout R, Dirani M, Teng T, Bianic F, Martin M, Holland R, Chemaly N, Coque N. Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers. Epilepsy Behav. 2020;108: 107094.","journal-title":"Epilepsy Behav"},{"key":"2697_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/dmcn.13601","volume":"60","author":"SH Licheni","year":"2018","unstructured":"Licheni SH, McMahon JM, Schneider AL, Davey MJ, Scheffer IE. Sleep problems in Dravet syndrome: a modifiable comorbidity. Dev Med Child Neurol. 2018;60:192\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"2697_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.seizure.2020.12.021","volume":"85","author":"A Van Nuland","year":"2021","unstructured":"Van Nuland A, Ivanenko A, Meskis MA, Villas N, Knupp KG, Berg AT. Sleep in Dravet syndrome: a parent-driven survey. Seizure. 2021;85:102\u201310.","journal-title":"Seizure"},{"key":"2697_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"2697_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ejpn.2019.02.014","volume":"23","author":"A Strzelczyk","year":"2019","unstructured":"Strzelczyk A, Kalski M, Bast T, Wiemer-Kruel A, Bettendorf U, Kay L, Kieslich M, Kluger G, Kurlemann G, Mayer T, Neubauer BA, Polster T, Herting A, von Spiczak S, Trollmann R, Wolff M, Irwin J, Carroll J, Macdonald D, Pritchard C, Klein KM, Rosenow F, Schubert-Bast S. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: a prospective, multicenter study from Germany. Eur J Paediatr Neurol. 2019;23:392\u2013403.","journal-title":"Eur J Paediatr Neurol"},{"key":"2697_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"2697_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1440-1819.2001.00830.x","volume":"55","author":"Y Doi","year":"2001","unstructured":"Doi Y, Minowa M, Uchiyama M, Okawa M. Subjective sleep quality and sleep problems in the general Japanese adult population. Psychiatry Clin Neurosci. 2001;55:213\u20135.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2697_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69\u201377.","journal-title":"J Psychosom Res"},{"key":"2697_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpsychores.2011.01.005","volume":"71","author":"A Hinz","year":"2011","unstructured":"Hinz A, Brahler E. Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res. 2011;71:74\u20138.","journal-title":"J Psychosom Res"},{"key":"2697_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2014.920296","author":"H Grau","year":"2014","unstructured":"Grau H, Graessel E, Berth H. The subjective burden of informal caregivers of persons with dementia: extended validation of the German language version of the Burden Scale for Family Caregivers (BSFC). Aging Mental Health. 2014. https:\/\/doi.org\/10.1080\/13607863.2014.920296.","journal-title":"Aging Mental Health"},{"key":"2697_CR29","unstructured":"Gr\u00e4\u00dfel E. H\u00e4usliche-Pflege-Skala HPS zur Erfassung der Belastung bei betreuenden oder pflegenden Personen [Burden Scale for Family Caregivers BSFC for the assessment of subjective burden]. In. Ebersberg: Vless; 2001."},{"key":"2697_CR30","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: L. Erlbaum Associates; 1988."},{"key":"2697_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.sleep.2016.03.008","volume":"30","author":"A Hinz","year":"2017","unstructured":"Hinz A, Glaesmer H, Brahler E, Loffler M, Engel C, Enzenbach C, Hegerl U, Sander C. Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med. 2017;30:57\u201363.","journal-title":"Sleep Med"},{"key":"2697_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107377","volume":"112","author":"LD Bailey","year":"2020","unstructured":"Bailey LD, Schwartz L, Dixon-Salazar T, Meskis MA, Galer BS, Gammaitoni AR, Schad C. Psychosocial impact on siblings of patients with developmental and epileptic encephalopathies. Epilepsy Behav. 2020;112: 107377.","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"2697_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1528-1167.2011.03012.x","volume":"52","author":"JV Skluzacek","year":"2011","unstructured":"Skluzacek JV, Watts KP, Parsy O, Wical B, Camfield P. Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia. 2011;52(Suppl 2):95\u2013101.","journal-title":"Epilepsia"},{"key":"2697_CR34","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/epi.16099","volume":"60","author":"A Strzelczyk","year":"2019","unstructured":"Strzelczyk A, Schubert-Bast S, Bast T, Bettendorf U, Fiedler B, Hamer HM, Herting A, Kalski M, Kay L, Kieslich M, Klein KM, Kluger G, Kurlemann G, Mayer T, Neubauer BA, Polster T, von Spiczak S, Stephani U, Trollmann R, Wiemer-Kruel A, Wolff M, Irwin J, Carroll J, Pritchard C, Rosenow F. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany. Epilepsia. 2019;60:1697\u2013710.","journal-title":"Epilepsia"},{"key":"2697_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yebeh.2017.05.037","volume":"74","author":"E Losito","year":"2017","unstructured":"Losito E, Kuchenbuch M, Chemaly N, Laschet J, Chiron C, Kaminska A, Nabbout R. Age-related, \u201cSleep\/nocturnal\u201d tonic and tonic clonic seizure clusters are underdiagnosed in patients with Dravet Syndrome. Epilepsy Behav. 2017;74:33\u201340.","journal-title":"Epilepsy Behav"},{"key":"2697_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11818-016-0097-x","volume":"21","author":"D Riemann","year":"2017","unstructured":"Riemann D, Baum E, Cohrs S, et al. S3-Leitlinie Nicht erholsamer Schlaf\/Schlafst\u00f6rungen. Somnologie. 2017;21:2\u201344.","journal-title":"Somnologie"},{"key":"2697_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s004060170066","volume":"251","author":"J Backhaus","year":"2001","unstructured":"Backhaus J, Hohagen F, Voderholzer U, Riemann D. Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci. 2001;251:35\u201341.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2697_CR38","doi-asserted-by":"crossref","unstructured":"Sim\u00f3n MA, Bueno AM, Otero P, Blanco V, V\u00e1zquez FL. Caregiver burden and sleep quality in dependent People's family caregivers. J Clin Med 2019;8.","DOI":"10.3390\/jcm8071072"},{"key":"2697_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/epi4.12241","volume":"3","author":"C Reilly","year":"2018","unstructured":"Reilly C, Atkinson P, Memon A, Jones C, Dabydeen L, Cross JH, Das KB, Gillberg C, Neville BGR, Scott RC. Child and parental sleep in young children with epilepsy: a population-based case-control study. Epilepsia Open. 2018;3:383\u201391.","journal-title":"Epilepsia Open"},{"key":"2697_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107340","volume":"112","author":"H Yang","year":"2020","unstructured":"Yang H, Feng Y, Zhu Z, Qiao Z, Xiao B, Feng L. Evaluation of anxiety, depression, and sleep quality among parents of children with epilepsy in Southern China. Epilepsy Behav. 2020;112: 107340.","journal-title":"Epilepsy Behav"},{"key":"2697_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.braindev.2011.04.011","volume":"34","author":"T Ikeda","year":"2012","unstructured":"Ikeda T, Nagai T, Kato-Nishimura K, Mohri I, Taniike M. Sleep problems in physically disabled children and burden on caregivers. Brain Dev. 2012;34:223\u20139.","journal-title":"Brain Dev"},{"key":"2697_CR42","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.ridd.2009.07.007","volume":"30","author":"J Chu","year":"2009","unstructured":"Chu J, Richdale AL. Sleep quality and psychological wellbeing in mothers of children with developmental disabilities. Res Dev Disabil. 2009;30:1512\u201322.","journal-title":"Res Dev Disabil"},{"key":"2697_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13023-021-01954-7","volume":"16","author":"X Li","year":"2021","unstructured":"Li X, Liu M, Lin J, Li B, Zhang X, Zhang S, Lu Z, Zhang J, Zhou J, Ou L. A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China. Orphanet J Rare Dis. 2021;16:327.","journal-title":"Orphanet J Rare Dis"},{"key":"2697_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00002820-200603000-00003","volume":"29","author":"PA Carter","year":"2006","unstructured":"Carter PA. A brief behavioral sleep intervention for family caregivers of persons with cancer. Cancer Nurs. 2006;29:95\u2013103.","journal-title":"Cancer Nurs"},{"key":"2697_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40263-022-00898-1","volume":"36","author":"A Strzelczyk","year":"2022","unstructured":"Strzelczyk A, Schubert-Bast S. A practical guide to the treatment of Dravet syndrome with anti-seizure medication. CNS Drugs. 2022;36:217\u201337.","journal-title":"CNS Drugs"},{"key":"2697_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/WCO.0000000000000902","volume":"34","author":"L Lagae","year":"2021","unstructured":"Lagae L. Dravet syndrome. Curr Opin Neurol. 2021;34:213\u20138.","journal-title":"Curr Opin Neurol"},{"key":"2697_CR47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s40263-022-00955-9","volume":"36","author":"A Strzelczyk","year":"2022","unstructured":"Strzelczyk A, Schubert-Bast, S. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs. 2022,36:1079\u2013111.","journal-title":"CNS Drugs"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02697-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02697-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02697-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T11:05:31Z","timestamp":1682766331000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02697-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2697"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02697-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,29]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethics approval by the Goethe-University Frankfurt (reference 40\/19) and all participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MM reports grants from GW Pharmaceuticals. SSB reports personal fees from Eisai, Desitin Pharma, GW Pharmaceuticals, Zogenix, UCB Pharma, and Marinus Pharma. TB has received support from Bial, Desitin Arzneimittel, Eisai, GW Pharmaceuticals, Neuraxpharm, Nutricia, Shire, Takeda, UCB Pharma, and Zogenix. RT reports personal fees from Desitin Pharma, Eisai, and Novartis. MW reports personal fees from Zogenix, Desitin, and Praxis Precision Medicines. KAK reports personal fees from Eisai, GW Pharmaceuticals, Zogenix, and Neuraxpharm. JJ reports personal fees from Eisai, Pendopharm, UCB Pharma, and Epilog. Her research is supported by NSERC and the Alberta Children\u2019s Hospital Foundation. GKu reports honoraria for speaking engagements from Desitin Arzneimittel, Eisai, UCB Pharma, Takeda, Shire, Zogenix, Neuraxpharm, Stada, and GW Pharmaceuticals. SS reports personal fees from Zogenix and fees from Eisai, UCB Pharma, and Nutricia paid to his department. AB reports grants from UCB Pharma and honoraria for speaking engagements from Biogen, Desitin Arzneimittel, Eisai GmbH, GW Pharmaceuticals, Neuraxpharm, Shire\/Takeda GmbH, UCB Pharma, and ViroPharma. FR reports personal fees from Angelini Pharma\/Arvelle Therapeutics, Eisai, GW Pharmaceuticals\/Jazz Pharma, and UCB Pharma and grants from the Detlev-Wrobel-Fonds for Epilepsy Research, the Deutsche Forschungsgemeinschaft (DFG), the Federal Ministry of Education and Research (BMBF), the LOEWE Programme of the State of Hesse, and the European Union. LK reports personal fees from GW Pharmaceuticals. AS reports personal fees and grants from Angelini Pharma, Desitin Arzneimittel, Eisai, GW\/Jazz Pharmaceuticals, Marinus Pharma, Precisis, Takeda,\u00a0UCB Pharma, UNEEG Medical, and Zogenix. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}